Surgical procedures associated with tissue injury are often followed by increased sensitivity to innocuous and noxious stimuli in the vicinity of the surgical wound. The aim of this study was to evaluate the role of transient receptor potential vanilloid 1 receptor (TRPV1) containing nociceptors in this process, by their functional inactivation using a high-concentration intradermal injection of capsaicin in a rat plantar incision model. Paw withdrawal responses to mechanical stimuli (von Frey filaments 10-367mN) and to radiant heat applied on plantar skin were tested in animals treated with capsaicin or the vehicle 6 days and 24h before or 2h after the incision was made. In the vehicle-treated animals, mechanical and thermal sensitivity increased significantly 1-96h following the incision. Capsaicin applied 24h before the surgery was most effective and significantly diminished the development of post-incisional mechanical allodynia and hyperalgesia. Thermal hypoalgesia was present in the incised paw after the capsaicin treatment. Capsaicin application 6 days before the incision induced thermal hypoalgesia before the incision but did not prevent completely the thermal hyperalgesia after the incision, while there was also a reduction of mechanical hypersensitivity. Application of the capsaicin injection after the incision showed its first effect at 2h after the injection and at 24h the effect was comparable with the 6 days pretreatment. Our results show an important role of TRPV1-containing nociceptors in the development of post-surgical hypersensitivity and suggest that local, high-concentration capsaicin treatment could be used to reduce it.

Department of Functional Morphology Institute of Physiology Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Bjerring P, Arendt-Nielsen P. Use of a new argon laser technique to evaluate changes in sensory and pain thresholds in human skin following capsaicin treatment. Skin Pharmacol. 1989;2:162-167.

Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain. 1996;64:493-501.

Carter RB, Francis WR. Capsaicin desensitization to plasma extravasation evoked by antidromic C-fiber stimulation is not associated with antinociception in the rat. Neurosci Lett. 1991;127:43-45.

Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci. 2001;24:487-517.

Chung JM, Lee KH, Hori Y, Willis WD. Effects of capsaicin applied to a peripheral nerve on the responses of primate spinothalamic tract cells. Brain Res. 1985;329:27-38.

Chung K, Klein CM, Coggesgall RE. The receptive part of the primary afferent axon is most vulnerable to systemic capsaicin in adult rats. Brain Res. 1990;511:222-226.

Dolin SJ, Cashman JN, Bland JM. Effectiveness of acute postoperative pain management: I Evidence from published data. Br J Anaesth. 2002;3:409-423.

Dux M, Sann H, Schemann M, Jancso G. Changes in fibre populations of the rat hairy skin following selective chemodenervation by capsaicin. Cell Tissue Res. 1999;296:471-477.

Fitzgerald M, Woolf CJ. The time course and specificity of the changes in the behavioural and dorsal horn cell responses to noxious stimuli following peripheral nerve capsaicin treatment in the rat. Neuroscience. 1982;7:2051-2056.

Gallar J, Pozo MA, Rebollo I, Belmonte C. Effects of capsaicin on corneal wound healing. Invest Ophthalmol Vis Sci. 1990;31:1968-1974.

Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, et al. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther. 2005;314:410-421.

Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991;43:143-201.

Jancso G, Kiraly E, Jancso-Gabor A. Direct evidence for an axonal site of action of capsaicin. Naunyn Schmiedebergs Arch Pharmacol. 1980;313:91-94.

Jancso G, Kiraly E, Such G, Joo F, Nagy A. Neurotoxic effect of capsaicin in mammals. Acta Physiol Hung. 1987;69:295-313.

Jakab B, Helyes Z, Varga A, Bolcskei K, Szabo A, Sandor K, et al. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421(SC0030) in vitro and in vivo in the rat. Eur J Pharmacol. 2005;517:35-44.

Karai L, Brown DC, Mannes AJ, Connelly ST, Brown J, Gandal M, et al. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest. 2004;113:1344-1352.

Malmberg AB, Mizisin AP, Calcutt NA, von Stein T, Robbins WR, Bley KR. Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain. 2004;111:360-367.

Meyer RA. Cutaneous hyperalgesia and primary afferent sensitization. Pulm Pharmacol. 1995;8:187-193.

Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 1999;81:135-145.

Paice JA, Ferrans CE, Lashley FR, Shott S, Vizgirda V, Pitrak D. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage. 2000;19:45-52.

Pogatzki EM, Gebhart GF, Brennan TJ. Characterization of Adelta- and C-fibers innervating the plantar rat hindpaw one day after an incision. J Neurophysiol. 2002;87:721-731.

Pogatzki-Zahn EM, Shimizu I, Caterina M, Raja SN. Heat hyperalgesia after incision requires TRPV1 and is distinct from pure inflammatory pain. Pain. 2005;115:296-307.

Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain. 1989;38:99-107.

Simone DA, Ochoa J. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain. 1991;47:285-294.

Simone DA, Sorkin LS, Oh U, Chung JM, Owens C, LaMotte RH, et al. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol. 1991;66:228-246.

Simone DA, Nolano M, Johnson T, Wendelschafer-Crabb G, Kennedy WR. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci. 1998;18:8947-8959.

Sun X, Yokoyama M, Mizobuchi S, Kaku R, Nakatsuka H, Takahashi T, et al. The effects of pretreatment with lidocaine or bupivacaine on the spatial and temporal expression of c-Fos protein in the spinal cord caused by plantar incision in the rat. Anesth Analg. 2004;98:1093-1098.

Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 1999;51:159-212.

Szolscanyi J, Nagy J, Petho G. Effect of CP-96,345 a non-peptide substance P antagonist, capsaicin, resiniferatoxin and ruthenium red on nociception. Regul Pept. 1993;46:437-439.

Varga A, Nemeth J, Szabo A, McDougall JJ, Zhang C, Elekes K, et al. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci Lett. 2005;385:137-142.

Wahl P, Foged C, Tullin S, Thomsen C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol. 2001;59:9-15.

Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther. 2003;304:56-62.

Wallengren J, Chen D. Local skin lesions in the rat after subcutaneous deposition of capsaicin. Skin Pharmacol Appl Skin Physiol. 2002;15:154-165.

Whiteside GT, Harrison J, Boulet J, Mark L, Pearson M, Gottshall S, et al. Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol. 2004;141:85-91.

Winter J, Bevan S, Campbell EA. Capsaicin and pain mechanisms. Br J Anaesth. 1995;75:157-168.

Yoshimura M, Yonehara N, Ito T, Kawai Y, Tamura T. Effects of topically applied capsaicin cream on neurogenic inflammation and thermal sensitivity in rats. Jpn J Pharmacol. 2000;82:116-121.

Zahn PK, Brennan TJ. Primary and secondary hyperalgesia in a rat model for human postoperative pain. Anesthesiology. 1999;90:863-872.

Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions

Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist

TRPV1 antagonist attenuates postoperative hypersensitivity by central and peripheral mechanisms